Elisa Baldelli

10PUBLICATIONS
79CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 11, 2025
Concurrent Inhibition of the RAS-MAPK Pathway and PIKfyve Is a Therapeutic Strategy for Pancreatic Cancer.

Jonathan M DeLiberty, Mallory K Roach, Clint A Stalnecker

|Jun 06, 2024
Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer.

Jennifer E Klomp, J Nathaniel Diehl, Jeffrey A Klomp

|Dec 19, 2023
RHOAL57V drives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling.

Antje Schaefer, Richard G Hodge, Haisheng Zhang

|Nov 08, 2022
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer.

Craig M Goodwin, Andrew M Waters, Jennifer E Klomp

|Oct 08, 2021
PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine.

Elisa Baldelli, K Alex Hodge, Guido Bellezza

Pageof 2